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PI3K induces B-cell development 
and regulates B cell identity
Hend Abdelrasoul1,2, Markus Werner1, Corinna S. Setz1, Klaus Okkenhaug  3 & Hassan Jumaa1
Phosphoinositide-3 kinase (PI3K) signaling is important for the survival of numerous cell types and 
class IA of PI3K is specifically required for the development of B cells but not for T cell development. 
Here, we show that class IA PI3K-mediated signals induce the expression of the transcription factor 
Pax5, which plays a central role in B cell commitment and differentiation by activating the expression 
of central B cell-specific signaling proteins such as SLP-65 and CD19. Defective class IA PI3K function 
leads to reduction in Pax5 expression and prevents B cell development beyond the stage expressing 
the precursor B cell receptor (pre-BCR). Investigating the mechanism of PI3K-induced Pax5 expression 
revealed that it involves a network of transcription factors including FoxO1 and Irf4 that directly binds 
to the Pax5 gene. Together, our results suggest that PI3K signaling links survival and differentiation of 
developing B cells with B cell identity and that decreased PI3K activity in pre-B cells results in reduced 
Pax5 expression and lineage plasticity.
The development of B cells is a highly-regulated process with defined stages characterized by cell-surface mark-
ers and the recombination status of the immunoglobulin (Ig) genes1. The development along the B-cell lineage 
requires the coordinated action of a variety of transcription factors, of which Pax5 has emerged to be essential for 
lineage commitment2. Besides inducing transcription of important genes required for B-cell development such 
as Cd193 and Blnk (the gene encoding SLP-65; SH2-domain containing protein of 65 kDA, also known as BLNK 
or Bash)4, Pax5 represses transcription of B-lineage inappropriate genes, thereby enforcing B cell character2. 
Accordingly, Pax5-deficient mice have a severe B cell developmental block at the pro-B cell stage with progenitor 
B cells lacking the ability to proceed with B cell development. Furthermore, inactivation of Pax5 in mature B cells 
induces their de-differentiation and the ability to enter other hematopoietic lineages2.
During B-cell development, successful VDJ recombination of the Ig heavy chain genes (IgH) leads to generation 
of a μ heavy chain (μHC), which is crucial for expression of a precursor B cell receptor (pre-BCR)5,6. The pre-BCR 
complex comprises two μHCs associated with the surrogate light chain (SLC) components VpreB and λ5 and the sig-
nal transduction subunits Ig-α and Ig-β7. There is large body of evidence that autonomously induced pre-BCR signals 
are required for cell cycle progression and proliferation of developing B cells8. On the other hand, pre-BCR signals 
are equally required for subsequent pre-B cell differentiation to early immature B cells9. Hence, pre-BCR signaling 
activates two fundamentally different cellular processes, namely proliferation and differentiation.
The differentiation of pre-B cells and the initiation of Ig light chain gene (IgL) recombination are induced by 
pre-BCR dependent activation of SLP-659,10. Expression of SLP-65 in B cells depends entirely on Pax54 and inacti-
vation of the gene encoding SLP-65 blocks B cell development at the pre-B cell stage11–13. SLP-65-deficient B cells 
express increased amounts of pre-BCR on the surface and show enhanced proliferation, suggesting that SLP-65 
acts as tumor suppressor10,11. Indeed, activation of SLP-65 promotes exit from the cell cycle, down-regulation 
of pre-BCR expression and the initiation of IgL gene recombination by diminishing phosphoinositide-3 kinase 
(PI3K) activity9,10.
It has been shown that signals for B cell survival are mediated by class IA of PI3Ks, which are heterodimers 
consisting of a catalytic subunit (p110α, p110β or p110δ) that is coupled to one of five regulatory subunits (p85α, 
p85β, p55α, p55γ, p50α)14,15. Class IA PI3Ks become activated upon recruitment to the plasma-membrane by 
binding to adaptor proteins such as CD19 or B cell adaptor protein (BCAP)16. PI3K activity leads to the production 
of phosphatidylinositol-(3,4,5)-trisphosphate (PtdInsP3), which is required for membrane recruitment and subse-
quent activation of important signaling proteins including AKT (also known as protein kinase B or PKB)17,18. The 
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role of class IA PI3K in B cell development was first shown in mice deficient for the regulatory subunit p85α or for 
the catalytic subunit p110δ19–23. However, in these mice B cell development was only slightly blocked at the pre-B 
cell stage, indicating that B cell development is regulated by the redundant function of several PI3K subunits. In 
fact, combined inactivation of both p110α and p110δ catalytic subunits (p110αfl/fl/δD910A x CD2-Cre) results in a 
severe block at the pre-B cell stage while the pro-B cell numbers are significantly elevated in these mice24. Similarly, 
combined absence of AKT1 and AKT2 during B cell development leads to accumulation of pro-B and pre-B cells, 
whereas numbers of immature and mature B cells are decreased25. Together, these studies indicate that pre-B cells 
defective for class IA PI3K/AKT signaling are unable to proceed in differentiation25 suggesting that PI3K acts 
downstream of the pre-BCR and that expansion and survival of pro-B cells is independent of PI3K. Interestingly, 
only B cell development is blocked in the p110α/p110δ-double deficient mice, although both catalytic subunits 
were defective in early progenitors of both, B and T lymphocytes24. The finding that T-cell development was not 
affected by inactivation of p110α and p110δ suggests that class IA PI3K-dependent-signaling is crucial for acti-
vation of B cell-specific signaling cascades that particularly promote B cell development. However, it has recently 
been suggested that PI3K is activated only by the interleukin-7 receptor (IL-7R) and not by the pre-BCR in pre-B 
cells26,27. This appears to be in sharp contrast to the inevitable role of IL-7R in murine B and T cell development as 
compared to the dispensable role of PI3K specifically in T cell development.
Here, we explored the activation and function of class IA PI3K during early B cell development and found that 
it is activated by the pre-BCR and not by IL-7R. Moreover, we show that class IA of PI3K is required for B cell 
commitment and differentiation as it activates the expression of the B cell transcription factor Pax5.
Results
PI3K regulates Pax5 expression. Analysis of mice with impaired class IA PI3K in B/T lymphocyte pro-
genitors revealed that B cell development is selectively blocked at the pre-B cell stage24. To investigate class IA 
PI3K function in early B cells, we expressed constitutively active versions of p110α (myr-p110α) or AKT (myr-
AKT) in a bone marrow (bm)-derived wild type (wt) pre-B cell line (Fig. S1a). GFP-negative and empty vec-
tor-transduced cells behaved comparably. For the sake of simplicity only the latter will be shown in further 
experiments (Fig. 1a). As expected, phosphorylated AKT (pAKT) indicative of activation was increased in pre-B 
cells expressing myr-p110α or myr-AKT (Fig. 1a). Moreover, we found that Pax5 and CD19 expression was 
elevated in these cells (Fig. 1a and Fig. S1b and data not shown). Notably, neither myr-AKT nor myr-p110α did 
lead to IL-7 independent cell growth (data not shown). To confirm the finding that PI3K signaling induces Pax5 
expression, we treated the bm-derived wt pre-B cell line with the PI3K-inhibitor LY294002 at a concentration 
ensuring a robust decline in AKT activity while not interfering with cell viability at the time of analysis (Fig. 1b 
and Fig. S1c). The results show that inhibition of PI3K signaling interferes with Pax5 expression. Since Pax5 acti-
vates SLP-65 expression4 we tested whether class IA PI3K also regulates SLP-65. Indeed, treatment of cells from 
the bm-derived wt pre-B cell culture with the PI3K-inhibitor LY294002 led to downregulation of both Pax5 and 
SLP-65 protein expression (Fig. 1b). Consistent with the negative effect of activated PI3K, FoxO1-levels increased 
upon LY294002 application (Fig. 1b).
To test whether class IA PI3K-dependent regulation of Pax5 also acts in the presence of continuous pre-BCR 
signaling as well as for later B cell developmental stages, we utilized a SLP-65-deficient pre-B cell line (Fig. 1c) 
and primary mature B cells (Fig. 1d, Fig. S1d), respectively. Expression of Pax5 declined in both cell types upon 
inhibition of PI3K signaling on protein (Fig. 1c,d) and transcript level (Fig. 1e,f). Additionally, PI3K-mediated 
activation of Pax5 expression was also detected in pre-B and mature B cells of human origin (Fig. S1f,g). Together, 
class IA PI3K signaling activates Pax5 expression irrespective of the species and of the B cell developmental stage.
PI3K requires the pre-BCR but not the IL-7R. Besides pre-BCR, IL-7R-derived signals play important 
roles during early B cell development7. To test whether IL-7R activates PI3K signaling, we incubated bm-derived 
wt pre-B cells overnight in the absence of IL-7, treated the cells with IL-7 and after different incubation periods 
within 60 min we determined AKT phosphorylation. The results show that pAKT was not increased after IL-7 
treatment at any time point tested (Fig. 2a). To provide additional evidence for the dispensable role of IL-7 in 
PI3K activation, we used a bm-derived pre-B cell line carrying loxP-flanked IL-7Rα alleles allowing Cre-mediated 
deletion of IL-7Rα and thus abrogating IL-7R signaling28. Indeed, deletion of IL-7Rα showed no effect on the 
pAKT-levels (Fig. 2b and Fig. S2a). Moreover, absence of IL-7 further increased expression of CD19 by myr-AKT 
and myr-p110α (Fig. S1b). Since pre-BCR expressing cells can be further divided into (IL-7 responsive) large 
pre-B cells and (IL-7-non-responsive) small pre-B cells, we tested whether IL-7Rα deletion in IL-7-responsive 
large pre-B cells can affect the phosphorylation level of AKT. Indeed, even with this experimental setup, AKT 
phosphorylation was not changed after IL-7Rα deletion (Fig. S3a). These data demonstrate that IL-7R is unlikely 
to be essential for PI3K activation in early B cell development.
To test whether pre-BCR signaling activates PI3K signaling, we reconstituted the pre-BCR in a Rag2-deficient 
pro-B cell line. Since Rag2-deficient cells express an endogenous surrogate LC, introduction of μHC results in 
pre-BCR expression in these cells. The data show that μHC leads to increased AKT phosphorylation suggesting 
that both the pre-BCR and the BCR activate PI3K signaling (Fig. 2c). To confirm these data, we used additional 
μHCs including 2 randomly cloned μHCs from the spleen of wt mice (Fig. 2d). Interestingly, we found that 
pre-BCR-induced AKT phosphorylation is detectable within 24–72 h (Fig. 2d) and that AKT phosphorylation 
is decreased after this time period (Fig. S3b), suggesting that activation of PI3K signaling by the pre-BCR is a 
regulated process. In addition to the increase in pAKT, μHC expression in Rag2-deficient pro-B cells also resulted 
in elevated Pax5 levels (Fig. S3c). Together, our data suggest that signaling by the pre-BCR, and not by IL-7R, is 
required for stimulation of PI3K activity in early B cell development.
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Figure 1. PI3K regulates Pax5 expression. (a) Cells from a bone marrow (bm)-derived wildtype (wt) pre-B 
cell culture were transduced with constitutively active forms of AKT (myr-AKT), p110α (myr-p110α), or 
as control with empty vector (EV) and analyzed for pAKT and Pax5 expression by intracellular FACS. If not 
indicated otherwise, numbers in the histograms state the mean fluorescence intensity (MFI) of the respective 
GFP+ populations. (b) Cells from a bm-derived wt pre-B cell culture were treated with LY294002 or DMSO for 
16 h and analyzed for pAKT, Pax5, SLP-65 and FoxO1 expression by intracellular FACS. (c) Cells from a SLP-
65-deficient pre-B cell line were treated with LY294002 or DMSO for 12 h and pAKT and Pax5 expression was 
analyzed by intracellular FACS. (d) Murine mature B cells (CD43−) were isolated and treated with LY294002 or 
DMSO for 12 h, lysed and subjected to immunoblot for analysis of Pax5 expression. Actin served as a loading 
control. For original full-length blots see Fig. S1e. (e) Total RNA of SLP-65-deficient cells treated for 12 h with 
LY294002 or DMSO was isolated. Gapdh and Pax5 mRNA-levels were detected with specific primers by qRT-
PCR using the SYBR-Green detection method. Results are shown as mean ± SD of 2 independent experiments, 
run as duplicates. Statistical significance was calculated using the t-Test. (f) Total RNA of murine mature B 
cells treated with LY294002 or DMSO for 12 h was isolated. Gapdh and Pax5 mRNA-levels were detected with 
specific primers by qRT-PCR using the SYBR-Green detection method. Results are shown as mean ± SD of 2 
independent experiments, run as duplicates. Statistical significance was calculated using the Mann-Whitney 
Test. Data shown in Fig. 1a–d are representative of at least 3 independent experiments.
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PI3K signaling regulates plasticity of developing B cells. Our data show that class IA PI3K signaling is 
mediated by the pre-BCR and that PI3K activates Pax5 and SLP-65 expression, which are important for pre-B cell 
differentiation. This novel link suggests that PI3K signaling activates pre-B cell differentiation. To test the role of PI3K 
signaling in differentiation24, we used bone marrow cells from a p110α−/−/δD910A mouse to generate an IL-7-dependent 
pre-B cell line (Fig. 3a, hereafter referred to as p110dKO cells, Fig. S4a). Signaling through class IA PI3K was affected 
in p110dKO cells as shown by reduced levels of pAKT (Fig. 3a). In accordance with our previous findings, p110dKO 
cells showed reduced transcription of Pax5 (Fig. 3b) and of its target genes Cd19 and Blnk (encoding SLP-65) (Fig. 3c).
Since signaling through SLP-65 regulates pre-BCR expression, we tested whether PI3K-deficient p110dKO 
cells showed defective pre-BCR down-regulation10,11. Indeed, we detected increased pre-BCR expression on 
the surface of p110dKO cells (Fig. 3d). To confirm the block in pre-BCR signaling in p110dKO cells, we tested 
whether expression of myr-AKT was able to restore expression and function of SLP-65. Indeed, myr-AKT led 
to increased expression of Pax5, CD19 and SLP-65 as well as down-regulation of surface pre-BCR expression 
(Fig. 3e). To provide additional evidence for the importance of PI3K signaling in activation of Pax5 expression, 
we established an IL-7-dependent pre-B cell line from the bone marrow of mice carrying loxP-flanked alleles 
for p110α and p110δ, the main catalytic p110 subunits acting in B cells24 (Fig. 3f and Fig. S4b). Deletion of 
p110α/p110δ by retroviral transduction of Cre expression vector resulted in decreased pAKT and Pax5 expression 
(Fig. 3g–i) suggesting that PI3K activity is important for maintaining the transcriptional program of developing 
B cells.
Figure 2. Pre-BCR activates PI3K signaling, whereas IL-7R does not. (a) Cells from a bm-derived wt pre-B cell 
line were cultured overnight in presence or absence of IL-7. Viability of the cells was assessed by Sytox staining 
(left panel). Levels of pAKT were measured by FACS at the indicated time points following addition of IL-7 (10 
ng/ml) (right panel). Numbers in the dot plots indicate the percentages, numbers in the histogram plots indicate 
the MFI. (b) Cells from an IL-7Rαfl/fl bm-derived pre-B cell line were transduced with a 4-hydroxytamoxifen 
(4-OHT)-inducible form of Cre-recombinase (Cre-ERT2) or ERT2 as EV and treated with 4-OHT (induction) 
or EtOH (control) for 48 h. Viability of the cells was assessed by Sytox staining (left). Surface levels of IL-7Rα as 
well as intracellular levels of pAKT were determined by FACS analysis (right, top). Additionally, Cre-mediated 
deletion was confirmed by PCR using specific primers detecting the floxed or deleted IL-7Rα allele (right, 
bottom). PCR for SRP20 was used as loading control. For original full-length gel pictures see Figure S2b.  
(c) Cells from a Rag2-deficient pro-B cell line were retrovirally transduced with μHC (B1-8 HC), or μHC + λLC 
(BCR) and levels of pAKT were measured at day 2 upon transduction by FACS. Numbers in the histogram 
plots indicate the MFI. (d) Indicated μHCs were introduced into cells from a Rag2-deficient pro-B cell line as in 
(c) and analyzed at day 1 post transduction for levels of pAKT by FACS (left). Numbers in the histogram plots 
indicate the MFI. Indicated μHCs were expressed at least 3 times and the average MFI of pAKT FACS-analysis 
over all experiments is shown (right). Statistical significance was calculated using the t-Test. Data shown in 
Fig. 2a,b are representative of at least 3 independent experiments.
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Figure 3. PI3K-deficient cells are blocked in differentiation and show imperfect B lineage commitment. 
(a) p110dKO cells were stained for CD19, B220 (both surface) and μHC (ic, intracellular) or the respective 
isotype control and analyzed by FACS (left panel). Cells from bm-derived wt and p110dKO pre-B cell lines 
were analyzed for pAKT levels by intracellular FACS (right panel). (b,c) Total RNA was isolated from bm-
derived wt and p110dKO pre-B cell cultures to analyze Pax5, Cd19, Blnk, Csf1r and Notch1 mRNA levels with 
specific primers by qRT-PCR using the SYBR-Green detection method. Results are shown as mean ± SD of 2 
independent analyses, run as duplicates. Statistical significance was calculated using the Mann-Whitney Test 
or the t-Test. (d) FACS analysis of p110dKO cells for surface expression of the pre-BCR components μHC and 
λ5. Cells from a Rag2-deficient B cell culture served as negative control. Numbers indicate percentages of cells 
in the respective region. (e) p110dKO cells were retrovirally transduced with myr-AKT or the EV. Expression 
of Pax5, SLP-65 (both intracellular), CD19 and μHC (both surface) was analyzed by FACS at day 2 after 
transduction and compared with expression in untransduced bystander cells (control). Data are representative 
of at least 3 independent experiments. n. d.: not detectable. (f) An IL-7 dependent pre-B cell line was established 
www.nature.com/scientificreports/
6Scientific REPORts |  (2018) 8:1327  | DOI:10.1038/s41598-018-19460-5
PI3K deficiency results in unstable B cell commitment. Given the importance of Pax5 for B-cell lin-
eage specific gene expression, the link between class IA PI3K and Pax5 suggested that PI3K-deficient p110dKO 
pre-B cells show defective B-lineage gene expression because of reduced Pax5 activation. In fact, we detected 
transcripts of Csf1r and Notch1 (Fig. 3c). Csf1r encodes the colony stimulating factor 1 receptor (CSF1R), also 
known as macrophage colony-stimulating factor receptor (M-CSFR), which is usually expressed on macrophages 
and is repressed by Pax5 in B cells. Based on the presence of Csf1r transcripts in p110dKO cells we tested whether 
p110dKO cells were able to respond to macrophage-colony stimulating factor M-CSF, the ligand of CSF1R and 
the factor, essential for survival, growth and differentiation of macrophages29. In contrast to wt cells, p110dKO 
pre-B cells survived in medium containing M-CSF (Fig. 4a and Fig. S5a) and expressed the myeloid specific 
surface marker CD11b (Mac-1) (Fig. 4b) suggesting that failure to suppress CSF1R expression in p110dKO 
cells allows survival under myeloid culture conditions. We further confirmed that p110dKO cells surviving in 
M-CSF-supplemented culture conditions were of B cell lineage origin since both the original IL-7-dependent cell 
line and the M-CSF-dependent cell line showed the same VDJ recombination pattern (Fig. S5b). Additionally, we 
tested in vivo the potential of p110dKO to enter the T-cell lineage by injecting p110dKO cells into Rag2/common 
γ chain double deficient mice. Interestingly, we found that mice injected with p110dKO developed a thymus-like 
structure in which we could detect CD4−, CD8− as well as CD4+/CD8+ cells (Fig. S5c,d).
Since the analysis of p110dKO cells suggested a role of PI3K in B cell identity, we investigated whether block-
ing PI3K activity can induce lineage plasticity of PI3K-sufficient cells. Indeed, we detected elevated levels of 
Csf1r and Notch1 transcripts in cells from a bm-derived SLP-65-deficient pre-B cell line treated with LY294002 
(Fig. 4c). To test whether PI3K-inhibitor treatment enabled these cells to survive under non-B cell conditions, 
LY294002-treated cells were cultured in medium supplemented with M-CSF. In fact, LY294002-treated pre-B cells 
survived under myeloid conditions (Fig. 4c), indicating that PI3K-sufficient pre-B cells become responsive to a 
myeloid specific growth factor after inhibition of PI3K.
Together, these data suggest that PI3K-deficiency blocks B cell development at the pre-B cell stage due to the 
inability of PI3K-deficient pre-B cells to induce Pax5 and thus the differentiation program for developing B cells.
FoxO1 is involved in Pax5 regulation. To characterize the molecular mechanism underlying the 
PI3K-mediated activation of Pax5 we investigated the role of FoxO1, which is known to be a highly conserved 
downstream target of PI3K/AKT signaling and is essential for Ig gene recombination30,31. Signaling through class 
IA PI3K/AKT results in proteasomal degradation of FoxO1, whereas in the absence of PI3K-activity, FoxO1 
protein is stabilized32. In fact, we detected elevated levels of FoxO1 in p110dKO pre-B cells (Fig. 5a). To test 
whether FoxO1 was involved in the PI3K-dependent regulation of Pax5, we introduced a constitutively active 
form of FoxO1 (FoxO1-A3) or an empty control vector (EV) into cells from a bm-derived wt pre-B cell line and 
found that FoxO1-A3 led to reduced Pax5 expression (Fig. 5b,c). Furthermore, inducible Cre-mediated deletion 
of loxP-flanked FoxO1 in a bm-derived pre-B cell line resulted in higher expression of Pax5 (Fig. 5d and Fig. S2c).
Since FoxO1 has been shown to directly bind to the Pax5 gene33, we investigated whether FoxO1 represses 
Pax5 transcription through potential FoxO1-binding sites in the Pax5 gene. Two highly conserved, potential 
FoxO1-binding sites within the Pax5 gene locus were identified (Fig. 5e) and used for the generation of luciferase 
expression vectors. These vectors carry, upstream of a basal Vκ-promotor, 1 kb-fragments from the Pax5 gene 
containing or lacking the potential FoxO1-binding sites (Fig. 5f). However, no significant effects of these con-
served FoxO1-binding sites were observed on luciferase expression (Fig. 5g). These results suggest that FoxO1 
might regulate Pax5 through an indirect mechanism.
FoxO1 represses Pax5 by induction of Irf4. A search for transcription factors that are activated 
by FoxO1 revealed interferon regulatory factor 4 (Irf4) as a potential candidate for Pax5 regulation. In fact, 
the Irf4-promoter contains specific sites for FoxO1 binding and subsequent activation of Irf4 expression34. 
Furthermore, Irf4 was shown to bind the Pax5 gene within a recently identified enhancer region35. To investi-
gate the role of Irf4 in PI3K-dependent regulation of Pax5 expression, we confirmed that Irf4 is induced upon 
treatment of SLP-65-deficient pre-B cells with the PI3K inhibitor LY294002 (Fig. 6a) or after introduction of 
FoxO1-A3 into a bm-derived wt pre-B cell line (Fig. 6b). In line with these findings, p110dKO pre-B cells showed 
elevated levels of Irf4 transcripts (Fig. 6c). Notably, Irf8, which is structurally highly related to Irf4, was not 
regulated by PI3K (Fig. 6d) and did not suppress Pax5 expression (Fig. S6). To directly test whether Irf4 links 
FoxO1 to the regulation of Pax5 gene transcription, we transduced cells from a wt pre-B cell line with Irf4 expres-
sion vectors and found that Pax5 protein and transcript amounts were reduced after Irf4 expression (Fig. 6e,f). 
Additionally, we tested whether the inverse regulation of Irf4 and Pax5 can also be detected in human peripheral 
from bm of p110αfl/fl/p110δfl/fl mice. The respective cells were characterized by surface staining for CD19 and 
B220, or the respective isotype control and analyzed by flow cytometry. (g) Cells described in Fig. 3f were 
retrovirally transduced with a Cre-encoding expression vector or EV, respectively. Cre-mediated deletion of 
p110α and δ was confirmed by PCR using specific primers detecting floxed or deleted alleles. PCR for SRP20 
served as loading control. For original full-length gel pictures see Figure S4c. (h) Cells described in Fig. 3f were 
retrovirally transduced with a Cre-encoding expression vector or EV, respectively, and analyzed by intracellular 
FACS for pAKT and Pax5 expression. Numbers in the histogram plots indicate the MFI, depicted data are 
representative of at least 4 independent experiments. (i) Average MFIs of pAKT and Pax5 following Cre-
mediated p110α and p110δ deletion. Results are shown as mean ± SD of 4 independent experiments. Statistical 
significance was calculated using the t-Test.
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B cells. Indeed, PI3K-inhibition of freshly isolated mature B cells from peripheral blood led to increased IRF4 and 
lower PAX5, CD19 as well as BLNK gene transcription (Fig. 6g). Together, these data clearly suggest that class IA 
PI3K induces Pax5 by inhibiting FoxO1 and thereby relieving Irf4-repression of Pax5.
PI3K-responsive element (PIRE) in Pax5 gene. To further characterize the molecular link between 
PI3K, FoxO1, Irf4 and Pax5, we first confirmed the binding of Irf4 to the previously described Pax5 enhancer 
region35 containing two Irf binding motifs (Fig. 7a,b). To test whether class IA PI3K and Irf4 influence the activity 
of this enhancer region, we generated luciferase expression vectors using Pax5-derived DNA sequences contain-
ing or lacking the Irf4-binding sites (Fig. 7c, PIRE-basic Luc and mPIRE-basic Luc, respectively). Consistent with 
the described enhancer function of this Pax5 gene region, we found elevated luciferase expression in presence 
of the Irf4-binding motifs (Fig. 7d). Notably, inactivating these Irf4-binding motifs (mPIRE-basic Luc) abol-
ished this enhancer function (Fig. 7d). To test whether class IA PI3K activity affects the enhancer function, we 
treated cells expressing PIRE- or mPIRE-basic Luc with LY294002. Interestingly, luciferase expression declined 
upon PI3K inhibition in PIRE- but not mPIRE-expressing cells (Fig. 7e), indicating that the activity of class IA 
PI3K critically influences Pax5 enhancer function. Since our data, presented so far, suggested that class IA PI3K 
regulates Pax5 via Irf4, we tested next whether increased expression of Irf4 counteracts luciferase expression in 
PIRE-expressing cells. Indeed, enforced expression of Irf4 repressed PIRE-induced luciferase expression confirm-
ing the repressive effect of Irf4 on the fragment containing PIRE (Fig. 7f). Together, these results suggest that class 
IA PI3K controls B cell development by induction of Pax5 gene expression through the activation of the Pax5 
enhancer region.
Figure 4. PI3K signaling regulates B cell commitment and plasticity. (a) Cells from bm-derived wt and 
p110dKO pre-B cell lines were cultured either in the presence of IL-7, M-CSF, or without cytokines and 
analyzed by flow cytometry. Numbers indicate percentages of cells in the respective regions at day 7 after 
beginning of treatment. (Data are representative of at least 3 independent experiments). (b) FACS-analysis 
of CD11b expression of measured in cells from bm-derived wt and p110dKO pre-B cell lines cultured in the 
presence of IL-7 (upper panel). p110dKO cells were cultured in IL-7 or M-CSF supplemented medium and 
CD11b expression was assessed by FACS analysis at day 8 after beginning of treatment (lower panel). (c) Cells 
from a bm-derived SLP-65-deficient pre-B cell line were treated with LY294002 (30 μM) or solvent (DMSO) 
for 16 h and subsequently cultured in medium supplemented with M-CSF. Csf1r and Notch1 mRNA levels were 
determined with specific primers by qRT-PCR using the SYBR-Green detection method (left panel). Results are 
shown as mean ± SD of 2 independent analyses, run as duplicates. Statistical significance was calculated using 
the Mann-Whitney Test or the t-Test. Cells from the respective culture conditions were further analyzed by flow 
cytometry (right panel).
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Figure 5. PI3K regulates Pax5 via FoxO1. (a) Cells from bm-derived wt and p110dKO pre-B cell lines were 
analyzed by intracellular FACS for FoxO1. (b) Cells from a bm-derived wt pre-B cell line were transduced 
with a constitutively active form of FoxO1 (FoxO1-A3) or an EV control. Expression of Pax5 was assessed by 
intracellular FACS at day 2 after transduction in at least 3 independent experiments. Statistical significance was 
calculated using the t-Test. (c) Total RNA of cells from Fig. 5b was isolated to analyze transcript levels of Pax5. 
Hprt and Pax5 mRNA-levels were detected by qRT-PCR using the SYBR-Green detection method. Results are 
shown as mean ± SD of 2 independent experiments, run as duplicates. Statistical significance was calculated using 
the t-Test. (d) Cells from a FoxO1fl/fl bm-derived pre-B cell line were transduced with Cre-ERT2 or -ERT2. 4-OHT 
was applied to activate the Cre-ERT2 (induction), treatment with EtOH served as control. Expression levels of 
FoxO1 and Pax5 were analyzed by intracellular flow cytometry (left panel). The MFI of Pax5 upon deletion of 
FoxO1 was quantified (bar diagram). Statistical significance was calculated using the t-test. Deletion of the floxed 
FoxO1 allele was confirmed by PCR, SRP20 served as loading control (right). For original full-length gel pictures 
see Fig. S2d. Depicted data are representative of at least 3 independent experiments. (e) Sequences of two FoxO1-
binding motifs identified by the Encode Genome Project. Site 1 (P1) is located in intron 5, site 2 (P2) in intron 9 
of the murine Pax5 gene. P1 and P2 are highly conserved between man and mouse. Graphs were prepared using 
the WebLogo software. (f) Schematic overview of the luciferase expression vector harboring a Vκ21 promoter 
and a 1 kb fragment containing or lacking the potential FoxO1 binding sites shown in Fig. 5e. (g) WEHI cells were 
electroporated to introduce the empty vector (Vκ + Luciferase) or the indicated constructs containing or lacking 
the potential FoxO1 binding sites. Expression of luciferase was equalized to the rLUC(Renilla) expression in 
each sample and WEHI cells were cotransfected either with EV (CMV-EV) or with a vector encoding FoxO1-A3 
(CMV-FoxO1-A3). Data are representative of 3 (EV) and 4 (FoxO1-A3) independent experiments and luciferase 
expression was determined using the Dual-Luciferase Reporter Assay System (Promega).
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Discussion
The PI3K signaling pathway is essential for the development of pre-B cells and for the maintenance of mature B 
cells36. In this study, we show that the crucial role of PI3K in B cell differentiation is mediated by activating the 
expression of Pax5 through a mechanism involving FoxO1 and Irf4. Accordingly, the combined deficiency of 
p110α and p110δ in p110dKO pre-B cells results in severe alteration in the expression of Pax5 and Pax5-regulated 
genes, which are required for pre-B cell development. Our data point to FoxO1 and Irf4 as an important molec-
ular link between PI3K activity and Pax5 expression. Although it is conceivable that additional elements might 
be involved in the PI3K-mediated induction of Pax5, available data support the role of Irf4 as a potential link 
between PI3K signaling and Pax5 gene expression. For instance, it has been shown that Irf4-levels are elevated 
in p110δ-deficient mature B cells and that inhibition of p110δ induces Irf4 gene transcription37. The finding that 
FoxO1 directly binds to the Irf4 promoter and induces the expression of Irf4 suggests that PI3K activity represses 
Figure 6. FoxO1 induces Irf4 to repress Pax5. (a) Total RNA from a SLP-65-deficient pre-B cell line, treated 
with LY294002 or DMSO for 12 h, was isolated. Hprt and Irf4 mRNA-levels were detected with specific primers 
by qRT-PCR using the SYBR-Green detection method (n = 5). (b) Cells from a bm-derived wt pre-B cell line 
were transduced with FoxO1-A3 or EV and at day 1 post transduction total RNA was isolated. Expression of 
Hprt and Irf4 mRNA-levels were detected by qRT-PCR using a SYBR-Green detection method (n = 3). (c) Total 
RNA from p110dKO and bm-derived wt pre-B cell lines was analyzed for Hprt and Irf4 transcript levels by qRT-
PCR using the SYBR-Green detection method (n = 3). (d) Hprt and Irf8 mRNA-levels were detected in RNA 
from Fig. 6a with specific primers by qRT-PCR using the SYBR-Green detection method (n = 5). (e) Similar 
to FoxO1-A3 in Fig. 5b, cells from a bm-derived wt pre-B cell line were transduced with Irf4 or EV and Pax5 
expression was analyzed at day 2 after transduction by intracellular FACS. (f) Total RNA of cells from Fig. 6e 
was isolated to analyze transcript levels of Pax5. Hprt and Pax5 mRNA-levels were detected by qRT-PCR using 
the SYBR-Green detection method (n = 3). (g) Human mature B cells from peripheral blood were isolated, 
treated with LY294002 and analyzed for IRF4, PAX5, BLNK and CD19 transcripts (n = 3). Results are shown as 
mean ± SD, run as duplicates. Data are representative of 2 (c) or at least 3 (a,b, d–g) independent experiments. 
Statistical significance was calculated using the t-Test.
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Irf4 by activating the degradation of FoxO134. This is in agreement with our results showing that class IA PI3K 
signaling represses Irf4 thereby activating Pax5. Since the ability of Irf4 to function as a transcriptional repressor 
is well established38. Our results suggest that Irf4 represses Pax5 gene transcription by directly binding to the 
Figure 7. Irf4 directly represses Pax5 expression. (a) Schematic overview showing the location of the Pax5 
enhancer region within the Pax5 gene locus. (b) Irf-4 ChIP from cells of a SLP-65-deficient pre-B cell line. 
Amplified by qPCR was the enhancer region of Pax5 within exon 5 containing Irf4-binding sites (A and 
B). As control, amplification of a region 3.5 kb upstream of Pax5 enhancer was chosen. Both samples were 
normalized to mock control. (c) Schematic overview of the luciferase expression vector harboring a Vκ 
promoter and the respective Pax5 enhancer region containing or lacking the Irf4 binding sites. (d–f) WEHI 
cells were electroporated to introduce the empty vector (Vκ + Luciferase) or the indicated constructs containing 
or lacking the Irf4 binding sites. Expression of luciferase was equalized to the rLUC (Renilla) expression 
in each sample of co-transfected WEHI cells. In (e), WEHI cells were treated for 16 h with LY294002 upon 
electroporation and in (f), WEHI cells were co-transfected with either EV or with a vector encoding Irf4. Data 
are representative of at least 3 independent experiments and luciferase expression was determined using the 
Dual-Luciferase Reporter Assay System.
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enhancer region of the Pax5 gene. Notably, a previous study showed that a large fragment of the Pax5 enhancer 
containing the Irf4 binding site in addition to other transcription factors activated the transcription of Pax5 in a 
transient transfection assay35. Together with our data, this suggests that the outcome of Irf4 on Pax5 expression 
may depend on the activity of additional transcription factors that also bind to the Pax5 enhancer. Consequently, 
modulating the activity of the involved transcription factors during B cell development determines the effect of 
Irf4 on Pax5 expression. Moreover, the identification of FoxO1 regulating Irf4 provides a molecular rationale as to 
how SLP-65-activation results in Irf4-induction and thereby in initiation of κLC-expression39. Previous findings 
showed furthermore that Pax5 induces SLP-65, which downregulates PI3K and activates FoxO1 and Irf44,9,39, 
the FoxO1/Irf4-mediated repression of Pax5 interferes with SLP-65 expression, thereby regulating FoxO1/Irf4 
activation. Thus, SLP-65 amounts control the balance between Pax5 and FoxO1/Irf4 by regulating PI3K signaling 
activity and therefore, characterizing the exact roles of these transcription factors is essential for understanding 
pre-B cell commitment and differentiation.
The essential role of PI3K signaling in the initiation of pre-B cell differentiation is supported by studies that 
directly interfere with PI3K function in developing B cells. For instance, combined deletion of BCAP and CD19 
leads to severely impaired AKT activation upon BCR stimulation and the number of early pre-B cells is strongly 
increased in these mice16. In contrast, the number of late pre-B cells is markedly reduced, suggesting that, in the 
absence of both BCAP and CD19, the impaired activation of PI3K results in defective differentiation of large 
pre-B cells to the small pre-B cell stage16. This observation is in complete agreement with our finding that class 
IA PI3K-derived signals are required for inducing the expression of Pax5 and the downstream target SLP-65. In 
fact, p110dKO pre-B cells deficient for PI3K signaling, express reduced amounts of SLP-65 and high amounts of 
the pre-BCR on their cell surface. This suggests that the residual SLP-65 expression in p110dKO pre-B cells is not 
sufficient to activate SLP-65-dependent signaling that leads to pre-BCR down-regulation and further differentia-
tion10. Therefore, we propose that the amounts of Pax5 and SLP-65 at the onset of pre-BCR expression are insuf-
ficient to drive the differentiation processes. Increased PI3K signaling mediated by pre-BCR function results in 
elevated amounts of Pax5 and SLP-65 thereby activating the signaling cascade for differentiation. In line with this, 
the B cell developmental block in mice with impaired PI3K signaling, p110dKO mice, is similar to that observed 
in the absence of BCAP/CD19 or in SLP-65-deficient mice11,12,16.
A recently identified patient lacking p85α showed a severe block in B cell development while other hemato-
poietic lineages were basically not affected40. Importantly, the phenotype of this p85α patient resembles that of 
λ5- or SLP-65-deficient patients. Both λ5 and SLP-65 represent well-known components of pre-BCR assembly or 
signaling41,42. In contrast, IL-7Rα-deficient patients lack T cells but have normal B-cell numbers43,44. If IL-7R sig-
naling was essential for PI3K activation in developing B cells, PI3K-deficient patients were then expected to reveal 
a similar phenotype as IL-7R-deficient patients. Together, these findings support the view that PI3K activation is 
induced by pre-BCR signaling and that IL-7R is not essential for this process.
Notably, while B cell development is completely blocked in p110dKO mice, T cell development is not 
affected24. Moreover, our finding that p110dKO pre-B cells grow in vitro in IL-7 supplemented medium suggests 
that IL-7R dependent survival and proliferation signals do not require PI3K signaling. Together with our finding 
that p110dKO pre-B cells have reduced expression of Pax5 and SLP-65, the available data suggest that class IA 
PI3K activity is specifically important for the development of B cells.
The PI3K-mediated activation of Pax5 together with the well-established roles of PI3K signaling as key sign-
aling axis for B cell survival and of Pax5 as essential factor for B cell development point to an unexpected mech-
anism, in which Pax5-mediated B cell differentiation is linked to survival. In this scenario, differentiation is a 
consequence of survival and proliferation. The molecular link between B cell survival and differentiation ensures 
that pre-BCR-mediated activation of class IA PI3K leads to B cell-specific gene expression and explains the spe-
cific importance of PI3K for B cell development. Our finding that PI3K is also required for Pax5 expression in 
mature B cells suggests that the BCR-generated survival signals, which are mediated by class IA PI3K14, maintain 
Pax5 expression at later developmental stages.
It should be noted, however, that certain amounts of Pax5 are expressed in developing cells before presence 
of μHC suggesting that other signaling pathways such as IL-7R are involved in the activation of Pax5 expres-
sion. IL-7R signals, which are known to activate survival and proliferation of pro-B cells45, may contribute to 
the induction of Pax5 expression by activation of STAT5 and Ebf1 that bind to the Pax5 gene46–49. However, it is 
unlikely that IL-7R activates Pax5 expression by induction of PI3K signaling. In fact, no change in phosphoryl-
ation of AKT was detected upon ablation of IL-7Rα gene expression. Furthermore, the defective PI3K signaling 
in p110dKO mice led to a developmental block at the pre-B cell stage indicating that pro-B cells, which require 
IL-7 for survival, proceed normally through early developmental stages in the absence of PI3K. Thus, together 
with our results, the available data suggest that IL-7R might be involved in the induction of Pax5 expression by 
activation of STAT5 or Ebf1 but not by PI3K activation, which is specifically activated by the pre-BCR.
Notably, our study is in disagreement with previous findings suggesting that IL-7R signaling activates PI3K 
signaling and that attenuation of this IL-7R-induced PI3K-signaling is required for induction of Pax5 and thus 
pre-B cell differentiation27. However, the previous study mainly utilized Irf4/Irf8 double deficient pre-B cells and 
it is unclear how the absence of Irf4 influences the obtained results27. Since we identified Irf4 as critical regulator 
of Pax5 expression and Pax5 as important target for PI3K-mediated activation, it is conceivable that the lack of 
Irf4 may affect the regulation of PI3K signaling in the Irf4-deficient cells. Importantly, the ability of Irf4 to control 
Pax5 expression is supported by available reports showing that Irf4 represses Pax5 gene expression50. In addition, 
available data show that the pre-BCR is only transiently expressed during early B cell development suggesting that 
its signaling activity is tightly regulated. Thus, experiments measuring induction of AKT phosphorylation after 4 
days of reconstitution of pre-BCR expression in Rag2-deficent cells cannot detect any pAKT induction most likely 
because the transient pre-BCR signaling was terminated.
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Our data suggest that the transient pre-BCR expression and function regulate the switch from proliferation 
to differentiation. During early phases of of pre-BCR signaling proliferation is induced and at the same time the 
expression of genes required for differentiation such as SLP-65 is activated. Induction of SLP-65 function down-
stream of the pre-BCR signaling down-regulates PI3K activity and allows differentiation. This scenario is in full 
agreement with our previous results elucidating the role of SLP-659 and explains why deficiencies in Pax5, SLP-65, 
Irf4 or PI3K signaling are blocked at the pre-B cell stage of differentiation.
Moreover, we believe that characterization of the role of PI3K in regulating Pax5 expression and B cell com-
mitment improves our understanding of general differentiation processes, as it elucidates how commitment, 
development and differentiation are regulated by a survival pathway such as PI3K, thereby maintaining the iden-
tity of the developing B cells. It is tempting to speculate that similar signaling networks exist in other hematopoie-
tic lineages and might be exploited to regulate the differentiation, survival or proliferation of hematopoietic cells.
Experimental Procedures
Ethics statement. Wildtype (wt), SLP-65-deficient11, FoxO1fl/fl 51, p110α−/−/p110δD910A 24, p110αfl/fl/p110δfl/fl 52,53, 
and IL-7Rαfl/fl 28 mice were used in this study. 8 to 10 weeks old Rag2/common γ chain double deficient mice54 
were used for adoptive transfer of p110dKO cells. All experiments involving animals were reviewed and approved 
by the institutional animal care and use committee of Ulm University Medical Center and the Max-Planck-
Institute of Immunobiology and Epigenetics. All methods were performed in compliance with the humane 
care and use of laboratory animals and the german animal welfare law. Buffy coats used for the preparation of 
human peripheral B cells were purchased from the Transfusion Center of Ulm University Medical Center (Institut 
für Klinische Transfusionsmedizin und Immungenetik Ulm GmbH, Ulm, Germany) and were obtained from 
anonymized healthy blood donors. All blood donors gave written informed consent to approve and authorize the 
use of their blood for medical, pharmaceutical, and research purposes.
Cell culture and biochemistry. For generation of pro-/pre-B cell lines, we isolated bone marrow from the 
respective mice to generate IL-7-dependent pre-B cell lines. Freshly isolated murine cells were therefore cultured 
in Iscove’s medium containing 10% heat inactivated FCS (Vitromex), 2 mM L-glutamine, 100 U/ml penicillin, 
100 U/ml streptomycin (Invitrogen), 5 × 10−5 M 2-mercaptoethanol and IL-7. IL-7 was produced in-house as a 
sterile-filtered supernatant of J558L cells. Culturing of primary bone marrow cells with medium containing IL-7 
results in rapid enrichment of early B cells and finally in stably growing cell lines, which importantly can be prop-
agated independent from feeder cell lines. This system to establish stable IL-7-dependent B cell cultures has been 
used by us and others extensively. Hallmark of this system is that all generated cell lines are dependent on exoge-
nous IL-7 provided in cell culture medium. Consequently, withdrawal of IL-7 leads to rapid cell death of the cell 
lines (see Fig. 4a and data not shown). M-CSF was produced with help of the M-CSF producing L929S cell line 
(kindly provided by M. Freudenberg) or purchased from Immunotools. Mature B cells were isolated from mouse 
spleens by using negative selection with anti-CD43 MACS-beads (Miltenyi Biotec) and cultured in medium with-
out IL-7. Human peripheral B cells (CD19+) were isolated by FACS sorting. The human pre-B cell line Nalm-6 
and the mature B cell line SU-DHL-6 were cultured in medium without addition of IL-7. For inhibition of PI3K, 
SLP-65-deficient pre-B cells and bone marrow derived wt pre-B cells were treated with 30 μM LY294002 (Merck 
Biosciences), Nalm-6 and SU-DHL-6 cells with 50 μM LY294002 for the indicated time points. Freshly isolated 
primary mature murine B cells were treated with 15 μM LY294002 for the indicated time points. Stable grow-
ing cell lines of FoxO1fl/fl (either IL-7 dependent or transformed by BCR-ABL) or IL-7Rαfl/fl (IL-7 dependent) 
bm-derived pre-B cells were retrovirally transduced with tamoxifen-inducible Cre-recombinase (ERT2-Cre) or 
empty control vectors and subsequently selected by addition of puromycin. Cre-recombinase was activated by 
addition of 2 μM 4-hydroxytamoxifen (4-OHT). As a control cells were treated with EtOH (solvent of 4-OHT).
PCR and RT-PCR. Total RNA was isolated from B cells using Trizol reagent (Invitrogen) or RNeasy Plus 
Mini KIT MiniPrep (Qiagen). The synthesis of cDNA was performed as previously described39. Gene expression 
was determined with gene specific primers using the SYBR-Green detection method (Applied Biosystems) and a 
7500 Fast Real-Time PCR machine (Applied Biosystems). Results were calculated by the ∆CT-Method. Generally, 
sequences of all primers in this study are available upon request.
Immunoblotting. For immunoblotting, 1.5 × 106 cells per sample were harvested and lysed in 50 μl modi-
fied RIPA buffer (50 mM TrisHCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA 
(pH 8), 1 mM sodium orthovanadate, 1 mM NaF and protease inhibitor cocktail (Sigma-Aldrich)). Lysates 
were separated on 10% SDS-polyacrylamide gels and transferred to PVDF membranes (Millipore). Membranes 
were blocked with 5% dry milk in PBT (PBS, 0.1% Tween-20) for 1 h at room temperature with constant agi-
tation. Primary antibodies were diluted in PBT supplemented with 4% BSA fraction V (BIOMOL Research 
Laboratories). Secondary antibodies were diluted in blocking solution. Immunoreactive antibodies used were 
anti-Pax5 (Abcam), anti-FoxO1 (Cell Signaling Technologies), and anti-Actin (I-19, Santa Cruz Biotechnology).
Flow Cytometry. Cells were surface-stained and analyzed by flow cytometry on LSRII flow cytometers 
(Becton Dickinson) using Cy5-, APC- or FITC-anti-IgM (μ-chain-specific, Southern Biotech), PE-anti-λ5 
(LM34, a gift from A. G. Rolink), PE-Cy7-B220 (eBioscience), PE-B220 (BD Pharmingen) APC-CD19 (eBi-
oscience), PE-CD43 (BD Pharmingen), PE-κ (Southern Biotech), PE-CD11b (eBioscience) and APC-CD127 
(eBioscience). Intracellular stainings were performed using Fix and Perm cell permeabilization Kit (ADG) 
according to the manufacturer’s instructions. Antibodies used for intracellular FACS-staining were PE-anti-Pax5 
(eBioscience), anti-SLP-65 (monoclonal IgG mouse, self-produced), anti-AKT (Cell Signaling), anti-FoxO1 (Cell 
Signaling), pAKT (Cell Signaling), APC-anti-rabbit IgG1 (AbD Serotec) and APC-anti-mouse IgG (AbD Serotec). 
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PE-IgG2a κ (eBioscience), APC-IgG1 (eBioscience), APC-IgG2a κ (eBioscience) were used as isotype controls. 
PE-anti-Biotin (BioLegend), Alexa Fluor 647-anti-mouse-IgG Fab2 and Alexa Fluor 647-anti-rabbit-IgG Fab2 
were used as secondary antibodies or as staining controls, respectively when used without the primary antibody.
Plasmids and retroviral transduction. The plasmids for expression of the constitutively active mutant of 
AKT (myr-AKT), tamoxifen-inducible form of Cre (Cre-ERT2)9 and FoxO1-A355 have been described previously. 
Open reading frames encoding for the constitutively active mutant of p110α (myr-p110α), Cre-recombinase and 
the human Irf4 (hIrf4) were subcloned into the pMIG-backbone containing an IRES-GFP cassette, thereby gen-
erating pMIG-myr-p110α, pMIG-Cre or pMIG-hIrf4-IRES-GFP, respectively. Target cells were retrovirally trans-
duced as described previously9. In summary, the Phoenix retroviral producer cell line was transfected according 
to the manufacturer’s instructions using GeneJuice (Novagen). Retroviral supernatants were harvested after 36 
and 60 h and for the subsequent transduction, pre-B cells were mixed with supernatants and centrifuged at 300 g 
at 37 °C for 3 h.
Electroporation. WEHI cells were transfected with indicated constructs carrying upstream of Luciferase 
a Vκ21 promoter sequence as well as Renilla vector (rLuc) for normalization using NeonTM transfection System 
(Lifetechnologies). Luciferase levels were detected by help of Dual Luciferase Assay system (Promega).
Statistical analysis. P values < 0.05 were considered to be statistically significant (n. s. = not significant; 
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).
The datasets generated and analyzed during the current study are available from the corresponding author on 
reasonable request.
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